120 related articles for article (PubMed ID: 2891546)
1. Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens.
Rifo J; Pourrat M; Vavrek RJ; Stewart JM; Huidobro-Toro JP
Eur J Pharmacol; 1987 Oct; 142(2):305-12. PubMed ID: 2891546
[TBL] [Abstract][Full Text] [Related]
2. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites.
Llona I; Vavrek R; Stewart J; Huidobro-Toro JP
J Pharmacol Exp Ther; 1987 May; 241(2):608-14. PubMed ID: 2883302
[TBL] [Abstract][Full Text] [Related]
3. Involvement of postjunctional purinergic mechanisms in the facilitatory action of bradykinin in neurotransmission in the rat vas deferens.
Donoso MV; Huidobro-Toro JP
Eur J Pharmacol; 1989 Jan; 160(2):263-73. PubMed ID: 2547629
[TBL] [Abstract][Full Text] [Related]
4. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens.
Maas J; Rae GA; Huidobro-Toro JP; Calixto JB
Br J Pharmacol; 1995 Apr; 114(7):1471-7. PubMed ID: 7606350
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
7. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
Farmer SG; Burch RM; Dehaas CJ; Togo J; Steranka LR
J Pharmacol Exp Ther; 1989 Feb; 248(2):677-81. PubMed ID: 2537408
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin-induced biphasic response in the rat isolated stomach fundus: functional evidence for a novel bradykinin receptor.
Calixto JB; Medeiros YS
Life Sci; 1992; 50(7):PL47-52. PubMed ID: 1311792
[TBL] [Abstract][Full Text] [Related]
9. Pre- and postsynaptic bradykinin responses in the rat vas deferens: asymmetric distribution of the postsynaptic effect.
Huidobro-Toro JP; Herreros R; Pinto-Corrado A
Eur J Pharmacol; 1986 Mar; 121(3):305-11. PubMed ID: 3699098
[TBL] [Abstract][Full Text] [Related]
10. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
Saha JK; Sengupta JN; Goyal RK
J Pharmacol Exp Ther; 1990 Mar; 252(3):1012-20. PubMed ID: 2156987
[TBL] [Abstract][Full Text] [Related]
11. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens.
Scott P; Razzaque Z; Longmore J
Eur J Pharmacol; 2003 Jan; 458(3):319-25. PubMed ID: 12504789
[TBL] [Abstract][Full Text] [Related]
14. Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor.
Saha JK; Sengupta JN; Goyal RK
J Pharmacol Exp Ther; 1991 Oct; 259(1):265-73. PubMed ID: 1656023
[TBL] [Abstract][Full Text] [Related]
15. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
[TBL] [Abstract][Full Text] [Related]
16. The actions of kinin antagonists on B1 and B2 receptor systems.
Regoli D; Drapeau G; Rovero P; Dion S; D'Orléans-Juste P; Barabé J
Eur J Pharmacol; 1986 Apr; 123(1):61-5. PubMed ID: 2872074
[TBL] [Abstract][Full Text] [Related]
17. Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
Asghar AU; Wheeldon A; Coleman RA; Bountra C; McQueen DS
Eur J Pharmacol; 2000 Jun; 398(1):131-8. PubMed ID: 10856457
[TBL] [Abstract][Full Text] [Related]
18. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.
Farmer SG; Burch RM; Kyle DJ; Martin JA; Meeker SN; Togo J
Br J Pharmacol; 1991 Apr; 102(4):785-7. PubMed ID: 1649657
[TBL] [Abstract][Full Text] [Related]
19. DesArg9-D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a potent bradykinin B1 receptor antagonist.
Wirth K; Breipohl G; Stechl J; Knolle J; Henke S; Schölkens B
Eur J Pharmacol; 1991 Nov; 205(2):217-8. PubMed ID: 1667388
[TBL] [Abstract][Full Text] [Related]
20. Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.
Sipma H; den Hertog A; Nelemans A
Br J Pharmacol; 1995 Jul; 115(6):937-44. PubMed ID: 7582524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
